Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.
Niteesh K ChoudhryMuthiah VaduganathanBrian Lee ClaggettIan J KulacInder S AnandAkshay S DesaiJames C FangAdrian F HernandezPardeep S JhundMikhail Naum KosiborodMarc S SabatineSanjiv J ShahOrly VardenyJohn Joseph Valentine McMurrayScott D SolomonThomas Andrew GazianoPublished in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique identifiers: NCT01035255 & NCT01920711.